Buscar resultados de ensayos clínicos

Patrocinado por

Blood Coagulation Disorders, Inherited - 23 Studies Found

Estado Estudiar
Completed Nombre del estudio: Evaluation of Hemostasis in Bleeding and Thrombotic Disorders
Condición:
  • Blood Coagulation Disorders, Inherited
  • Thrombotic Disorder

    • Fecha: 2005-09-12
Completed Nombre del estudio: Education Program for Patients Receiving Oral Anticoagulation
Condición:
  • Cardiovascular Disease
  • Venous Thromboses
  • Atrial Fibrillati
    Fecha: 2011-04-13
    Intervenciones: Behavioral: Educational program Individual orientation (slides) during hospitalization period and teleph
Completed Nombre del estudio: A Gene Transfer Study for Hemophilia A
Condición: Hemophilia A
Fecha: 2016-12-16
Intervenciones: Genetic: SPK-8011 A novel, bio-engineered, recombinant adeno-associated viral vector carrying human fact
Withdrawn Nombre del estudio: Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia B
Condición: Hemophilia B
Fecha: 2013-11-14
Intervenciones: Biological: IB1001 Prophylaxis (during Treatment and Conti
Completed Nombre del estudio: BAY14-2222 Prophylaxis and Joint Function Improvement (Adults)
Condición:
  • Hematologic Disease
  • Hemophilia A

Fecha: 2007-12-21
Intervenciones: Drug: Kogenate (BAY14-2222) One group two treatment schedules, first on-demand then switch to prophylaxi
Completed Nombre del estudio: Epidemiology and Immunology of Hemophilia A Inhibitors
Condición:
  • Blood Disease
  • Hemophilia A

Fecha: 2000-05-25
Not yet recruiting Nombre del estudio: Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet Therapies
Condición: Hemophilia
Fecha: 2017-05-16
Intervenciones: Other: Non interventionnal study A query form to all concerned patients by each investigating centre wil
Available Nombre del estudio: An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors
Condición: Hemophilia A
Fecha: 2017-05-12
Intervenciones: Biological: Emicizumab Participants will receive emicizumab at a loading dose of 3 milligrams per kilogr
Not yet recruiting Nombre del estudio: DDAVP vs. Exercise
Condición: Children With Mild Hemophilia A
Fecha: 2017-04-27
Intervenciones:
  • Drug: DDAVP intervention For t
Not yet recruiting Nombre del estudio: Study of rFVIIIFc for ITI in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI Therapies
Condición: Hemophilia A
Fecha: 2017-03-31
Intervenciones: Biological: Recombinant coagulation factor (rFVIIIFc) rFVI
Next >>>